Allarity Therapeutics, Inc. Present Value of Future Insurance Profits, Amortization Expense, Realized Gain (Loss)
Allarity Therapeutics, Inc. (ALLR) reported Present Value of Future Insurance Profits, Amortization Expense, Realized Gain (Loss) of $1.75 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Income Statement › Other Income
us-gaap:PresentValueOfFutureInsuranceProfitsAmortizationExpenseRealizedGainLoss · last filed 2023-03-13
- Allarity Therapeutics, Inc. present value of future insurance profits, amortization expense, realized gain (loss) for fiscal 2022 was $1.75M, a 72.49% decline from fiscal 2021.
- Allarity Therapeutics, Inc. present value of future insurance profits, amortization expense, realized gain (loss) for fiscal 2021 was $6.37M, a 933.77% increase from fiscal 2020.
- Allarity Therapeutics, Inc. present value of future insurance profits, amortization expense, realized gain (loss) for fiscal 2020 was $616.00K.
| Period end | Present Value of Future Insurance Profits, Amortization Expense, Realized Gain (Loss) 12 month |
|---|---|
| 2022-12-31 | $1.75M 10-K · filed 2023-03-13 |
| 2021-12-31 | $6.37M 10-K · filed 2023-03-13 |
| 2020-12-31 | $616.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |